Observations placeholder
Robaxin and Robaxisal
Identifier
016881
Type of Spiritual Experience
Background
A description of the experience
Methocarbamol - trade name Robaxin - is a central muscle relaxant used to treat skeletal muscle spasms. In combination with acetaminophen (Paracetamol), its trade name is Robaxacet, whereas Robax Platinum is the trade name for a formulation of methocarbamol and ibuprofen. A combination of methocarbamol and aspirin is marketed as Robaxisal. Unlike other carbamates such as carisoprodol and meprobamate, Methocarbamol has “greatly reduced abuse potential”. Studies have “found that methocarbamol produces increased 'liking' responses and some sedative-like effects, however, at higher doses dysphoria is reported”. Potential side-effects include: drowsiness, dizziness, upset stomach, flushing, blurred vision, and fever. Serious side-effects include the development of a severe skin rash or itching, slow heart rate, fainting, jaundice, persistent nausea/vomiting, stomach/abdominal pain, mental/mood changes, clumsiness, trouble urinating, signs of infection. In addition, methocarbamol may cause urine to turn black, blue, or green. However, “this effect is harmless”! Because of potential for side-effects, this drug is on the list for High-Risk Medications in the elderly
On Jun, 8, 2015: 2,485 people reported to have side effects when taking Robaxin. Among them, 31 people (1.25%) have Hallucination.
On Jun, 24, 2015: 2,485 people reported to have side effects when taking Robaxin. Among them, 22 people (0.89%) have Death.
On Jun, 25, 2015: 25 people reported to have side effects when taking Robaxisal. Among them, 2 people (8.00%) have Death.